| Record ID | marc_loc_2016/BooksAll.2016.part41.utf8:128011033:1136 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part41.utf8:128011033:1136?format=raw |
LEADER: 01136cam a2200313 i 4500
001 2013944946
003 DLC
005 20140507082134.0
008 130710s2013 enk b 000 0 eng
010 $a 2013944946
020 $a9780857934499 (hbk.)
020 $a085793449X (hbk.)
040 $aDLC$beng$cDLC$erda$dDLC
042 $apcc
050 00 $aHD9665.5$b.P4955 2013
245 00 $aPharmaceutical economics /$cedited by William S. Comanor and Stuart O. Schweitzer.
264 1 $aCheltenham, UK :$bEdward Elgar,$c[2013]
300 $axxxiii, 739 pages ;$c25 cm.
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
490 0 $aThe international library of critical writings in economics ;$v284
490 0 $aAn Elgar research collection
504 $aIncludes bibliographical references.
650 0 $aPharmaceutical industry$xEconomic aspects.
650 0 $aPharmaceutical industry$xResearch$xEconomic aspects.
650 0 $aDrug development$xEconomic aspects.
700 1 $aComanor, William S.,$eeditor of compilation.
700 1 $aSchweitzer, Stuart O.,$eeditor of compilation.